Q1 2021 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED)2021-05-10 | ||||||
REV |
Q4 2020 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -0.320 | -0.330 | -0.0100 | ||||
REV | 0 |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|
Ticker | Company | Price | Change | Chg % | Mkt Cap | |
---|---|---|---|---|---|---|
ZYNE | Zynerba Pharmaceuticals | 3.90 | 0.07 | 1.83% | 160.9M |
You can purchase shares of Zynerba Pharmaceuticals (NASDAQ: ZYNE) through any online brokerage.
Other companies in Zynerba Pharmaceuticals’s space includes: Onconova Therapeutics (NASDAQ:ONTX), Xeris Pharmaceuticals (NASDAQ:XERS) and Satsuma Pharmaceuticals (NASDAQ:STSA).
The latest price target for Zynerba Pharmaceuticals (NASDAQ: ZYNE) was reported by Needham on 2020-07-01. The analyst firm set a price target for 0.00 expecting ZYNE to fall to within 12 months (a possible -100.00% downside). 2 analyst firms have reported ratings in the last year.
The stock price for Zynerba Pharmaceuticals (NASDAQ: ZYNE) is $3.9 last updated Today at 4:20:32 PM.
There are no upcoming dividends for Zynerba Pharmaceuticals.
There is no upcoming split for Zynerba Pharmaceuticals.